IBD Fecal Biomarkers: Scientific Findings & Clinical Applications
Inflammatory bowel disease (IBD) is diagnosed in an estimated 1.3% of U.S. adults. Fecal biomarkers are an accurate, cost-effective, and efficient way to assist in the diagnosis and management of chronic intestinal inflammation.
This accredited, on-demand, self-study course with complimentary CME and CEUs is for gastroenterologists, gastroenterology nurses, nurse practitioners, and laboratorians involved in the testing, diagnosis, treatment, and management of IBD.
Click on the View Learning Activity to study the slides and notes. When you are finished studying, you may click on CE Self-Assessment and complete the post-test and evaluation. Follow the instructions for achieving CE credit. You may also download the slide set to have for your files.
Scientific Advisors
Bincy Abraham
Bincy P. Abraham
MD, MS, AGAF, FACG

Director, Gastroenterology
Fellowship Program

Distinguished Professor and
Director, Fondren IBD Program
Houston Methodist

Associate Professor of Clinical Medicine, Weill Cornell Medical College

Adjunct Associate Professor
of Internal Medicine,
Texas A&M University

Paul Rufo
Paul A. Rufo
MD, MMSc

Attending Physician

Division of Gastroenterology, Hepatology and Nutrition

Director,
Harvard Medical School Fellowship
in Pediatric Gastroenterology

Assistant Professor of Pediatrics, Harvard Medical School

Planned and developed by Medavera and supported by an educational donation from TechLab, Inc.
©2020 Medavera. All rights reserved.
Inquiries: info@medavera.com